Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.

Saved in:
Bibliographic Details
Title: Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.
Authors: Kuser-Abali G; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Noguchi F; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Zhao P; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Szeto P; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Zhang Y; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Huang C; Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC 3800, Australia., Barlow CK; Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC 3800, Australia., Pomilio G; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3004, Australia., Boudes M; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Chew C; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Moghaddam SM; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Leece I; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Cheung JG; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Ameratunga M; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Wong NC; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia., Andrews MC; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Schittenhelm RB; Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC 3800, Australia., Wei A; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3004, Australia., Naranbhai V; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia., Davidovich C; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Shackleton M; Department of Cancer Medicine, Monash University, Melbourne, VIC 3004, Australia; Department of Oncology, Alfred Health, Melbourne, VIC 3004, Australia. Electronic address: mark.shackleton@monash.edu.
Source: Molecular cell [Mol Cell] 2026 Jul 02; Vol. 86 (13), pp. 2521-2538.e10.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9802571 Publication Model: Print Cited Medium: Internet ISSN: 1097-4164 (Electronic) Linking ISSN: 10972765 NLM ISO Abbreviation: Mol Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4164
DOI:10.1016/j.molcel.2026.06.003